Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Burk

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionI Rassmann, R Thödtmann, M Mross, et al.
Gynecologic Oncology|July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancerJ J Kavanagh, C L Edwards, R S Freedman, et al.
Investigational New Drugs|May 16, 2006
Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinomaC Bolling, T Graefe, C Lübbing, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2006
The alpha-synuclein gene in multiple system atrophyT Ozawa, D G Healy, P M Abou-Sleiman, et al.
Brain : a Journal of Neurology|June 11, 2005
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study GroupC Kamm, D G Healy, N P Quinn, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionI Rassmann, R Thödtmann, M Mross, et al.
Gynecologic Oncology|July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancerJ J Kavanagh, C L Edwards, R S Freedman, et al.
Investigational New Drugs|May 16, 2006
Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinomaC Bolling, T Graefe, C Lübbing, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2006
The alpha-synuclein gene in multiple system atrophyT Ozawa, D G Healy, P M Abou-Sleiman, et al.
Brain : a Journal of Neurology|June 11, 2005
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study GroupC Kamm, D G Healy, N P Quinn, et al.
Pageof 3